Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Bio Key International (BKYI) over the last 17 years, with Q3 2025 value amounting to $1.2 million.

  • Bio Key International's Accumulated Expenses fell 319.18% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 319.18%. This contributed to the annual value of $1.3 million for FY2024, which is 207.65% down from last year.
  • According to the latest figures from Q3 2025, Bio Key International's Accumulated Expenses is $1.2 million, which was down 319.18% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Bio Key International's Accumulated Expenses registered a high of $1.3 million during Q4 2023, and its lowest value of $535952.0 during Q1 2021.
  • Moreover, its 5-year median value for Accumulated Expenses was $1.0 million (2022), whereas its average is $986731.5.
  • Per our database at Business Quant, Bio Key International's Accumulated Expenses surged by 7496.22% in 2021 and then crashed by 1236.71% in 2025.
  • Over the past 5 years, Bio Key International's Accumulated Expenses (Quarter) stood at $828997.0 in 2021, then increased by 21.73% to $1.0 million in 2022, then rose by 29.4% to $1.3 million in 2023, then dropped by 2.08% to $1.3 million in 2024, then fell by 5.03% to $1.2 million in 2025.
  • Its Accumulated Expenses stands at $1.2 million for Q3 2025, versus $1.2 million for Q2 2025 and $1.0 million for Q1 2025.